Preethi Sundaram - Jul 6, 2021 Form 3 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
Chief Product Devel. Officer
Signature
/s/ Preethi Sundaram
Stock symbol
CPRX
Transactions as of
Jul 6, 2021
Transactions value $
$0
Form type
3
Date filed
7/13/2021, 04:44 PM
Next filing
Dec 30, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CPRX Options to purchase Common Stock Jul 6, 2021 Common Stock 300K $5.49 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options will vest in four equal tranches on July 6, 2022, 2023, 2024 and 2025.